Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World Study.
Soegiharto R, Van der Wind E, Alizadeh Aghdam M, Sørensen JA, Van Lindonk E, Bulut Demir F, Mohammad Porras N, Matsuo Y, Kiefer L, Knulst AC, Maurer M, Ritchie C, Rudenko M, Kocatürk E, Fachini Jardim Criado R, Gregoriou S, Bobylev T, Kleinheinz A, Takahagi S, Hide M, Giménez-Arnau AM, Salman A, Oztas Kara R, Sevimli Dikicier B, Van Doorn MBA, Thomsen SF, Van den Reek JMPA, Röckmann H. Soegiharto R, et al. Among authors: knulst ac. Clin Exp Allergy. 2025 Jun;55(6):481-492. doi: 10.1111/cea.70067. Epub 2025 May 5. Clin Exp Allergy. 2025. PMID: 40325793 Free PMC article.
Severity of almond allergy and diagnostic value of almond extract in adults.
Kallen EJJ, Welsing PMJ, Alves PB, Kuiken JE, Knulst AC, van Ree R, Le TM. Kallen EJJ, et al. Among authors: knulst ac. J Allergy Clin Immunol Pract. 2025 Jun;13(6):1485-1488. doi: 10.1016/j.jaip.2025.03.031. Epub 2025 Mar 27. J Allergy Clin Immunol Pract. 2025. PMID: 40157422 Free article. No abstract available.
Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study.
Soegiharto R, Alizadeh Aghdam M, Sørensen JA, van Lindonk E, Bulut Demir F, Mohammad Porras N, Matsuo Y, Kiefer L, Knulst AC, Maurer M, Ritchie C, Rudenko M, Kocatürk E, Criado RFJ, Gregoriou S, Bobylev T, Kleinheinz A, Takahagi S, Hide M, Giménez-Arnau AM, Salman A, Kara RO, Dikicier BS, van Doorn MBA, Thomsen SF, van den Reek JMPA, Röckmann H. Soegiharto R, et al. Among authors: knulst ac. Allergy. 2025 Feb;80(2):489-499. doi: 10.1111/all.16334. Epub 2024 Oct 8. Allergy. 2025. PMID: 39377745 Free PMC article.
Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.
Soegiharto R, Alizadeh Aghdam M, Sørensen JA, van Lindonk E, Bulut Demir F, Porras NM, Matsuo Y, Kiefer L, Knulst AC, Maurer M, Ritchie C, Rudenko M, Kocatürk E, Criado RFJ, Gregoriou S, Bobylev T, Kleinheinz A, Takahagi S, Hide M, Giménez-Arnau AM, Salman A, Kara RO, Sevimli Dikicier B, van Doorn MBA, Thomsen SF, van den Reek JMPA, Röckmann H. Soegiharto R, et al. Among authors: knulst ac. JAMA Dermatol. 2024 Sep 1;160(9):927-935. doi: 10.1001/jamadermatol.2024.2056. JAMA Dermatol. 2024. PMID: 39018068 Free PMC article.
235 results